Company: GOOGL
Filing Date: 2025-07-24
Form Type: 10-Q
Source: 0001652044-25-000062
Chunk: 37

Company: Alphabet Inc.
Filing Date: 2025-07-24
Form: 10-Q
Item: Part I, Item 1
Chunk 37
---
 gain (loss) on equity securities in other income (expense), net$(714)$1,286 $1,529 $11,044 (1)Unrealized gain (loss) on non-marketable equity securities accounted for under the measurement alternative is comprised of $319 million and $660 million of upward adjustments and $745 million and $454 million of downward adjustments (including impairments) for the three months ended June 30, 2024 and 2025, respectively, and $3.1 billion and $10.4 billion of upward adjustments and $1.6 billion and $853 million of downward adjustments (including impairments) for the six months ended June 30, 2024 and 2025, respectively.In the table above, realized net gain (loss) on equity securities sold during the period reflects the difference between the sale proceeds and the carrying value of the equity securities at the beginning of the period or the purchase date, if later.Cumulative net gains (losses) on equity securities sold during the period, which is summarized in the following table (in millions), represents the total net gains (losses) recognized after the initial purchase date of the equity security sold during the period. While these net gains (losses) may have been reflected in periods prior to the period of sale, we believe they are important supplemental information as they reflect the economic net gains (losses) on the securities sold during the period. Cumulative net gains (losses) are calculated as the difference between the sale price and the initial purchase price for the equity security sold during the period.Three Months EndedSix Months EndedJune 30,June 30, 2024202520242025Total sale price$583 $315 $1,673 $1,068 Total initial cost303 272 964 864 Cumulative net gains (losses)$280 $43 $709 $204 Equity Securities Accounted for Under the Equity MethodAs of December 31, 2024 and June 30, 2025, equity securities accounted for under the equity method had a carrying value of approximately $2.0 billion and $2.3 billion, respectively. Our share of gains and losses, including impairments, are included as a component of OI&E, in the Consolidated Statements of Income. See Note 7 for further details on OI&E. Certain of our equity method securities include our investments in V